MARKET

APOP

APOP

Cellect Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.78
-0.92
-13.73%
Closed 19:56 09/20 EDT
OPEN
6.55
PREV CLOSE
6.70
HIGH
6.55
LOW
5.70
VOLUME
380.51K
TURNOVER
--
52 WEEK HIGH
8.88
52 WEEK LOW
1.650
MARKET CAP
22.67M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 20h ago
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
Benzinga · 09/08 08:57
53 Biggest Movers From Friday
Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera Therapeutics, Inc. (NASDAQ: VERA) gained 32.7% to close at $25.80. Vera Therapeutics, la...
Benzinga · 09/07 08:58
JOBY, FTFT and CLIR among mid-day movers
Gainers: Cellect Biotechnology (NASDAQ:APOP) +29%. Katapult (NASDAQ:KPLT) +27%. Innate Pharma (NASDAQ:IPHA) +25%. MongoDB  (NASDAQ:MDB) +24%. Draganfly (NASDAQ:DPRO) +22%. Future FinTech (NASDAQ:FTFT) +18%. Neonode (NASDAQ:NEON) +18%. Impel NeuroPharma (NA...
Seekingalpha · 09/03 16:34
Sector Update: Health Care Stocks Stage Modest Recovery, Edging Higher Near Friday Close
MT Newswires · 09/03 16:09
Mid-Day Market Update: Gold Rises 1%; Forte Biosciences Shares Plunge
Midway through trading Friday, the Dow traded down 0.23% to 35,361.40 while the NASDAQ rose 0.02% to 15,333.95. The S&P also fell, dropping 0.22% to 4,527.17.
Benzinga · 09/03 16:03
Enveric Biosciences and Cellect Biotechnology among healthcare gainers; Forte Biosciences among losers
Gainers: Cellect Biotechnology (NASDAQ:APOP) +39%. NeuroOne Medical Technologies (NASDAQ:NMTC) +17%. Enveric Biosciences (NASDAQ:ENVB) +16%. Impel NeuroPharma (NASDAQ:IMPL) +12%. Progenity (NASDAQ:PROG) +10%. Losers: Forte Biosciences (NASDAQ:FBRX) -81%. E...
Seekingalpha · 09/03 14:55
Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August
Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66.
Benzinga · 09/03 14:10
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Balance SheetMore
Cash FlowMore
Learn about the latest financial forecast of APOP. Analyze the recent business situations of Cellect Bio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APOP stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 14
Institutional Holdings: 571.15K
% Owned: 14.56%
Shares Outstanding: 3.92M
TypeInstitutionsShares
Increased
1
6.31K
New
1
10.20K
Decreased
3
25.80K
Sold Out
5
37.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.58%
Pharmaceuticals & Medical Research
-1.08%
Key Executives
Chairman/Director
Nuriel Kasbian
Chief Executive Officer/Director
Shai Yarkoni
Chief Financial Officer
Eyal Leibovitz
Vice President - Research & Development
Amotz Nehushtan
Other
Yaron Pereg
Other
Guy Sapir
Director
Ruth Ben Yakar
Director
Michael Berelowitz
Non-Executive Director
Yuval Berman
Non-Executive Director
David Grossman
Independent Director
Abraham Nahmias
No Data
About APOP
Cellect Biotechnology Ltd is an Israel-based biotechnology company. Its technology platform, ApoGraft, selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies by using functional selection. Efficient selection enables retention of most of the stem cells while neutralizing harmful mature cells. ApoGraft exploit a functional characteristic of stem cells relating to apoptosis, which is the process of programmed cell death and is a vital part of physiological development and homeostasis of all organisms. Stem cells flourish in an environment where normal cells die because their main role is reconstitution of damaged tissue. The platform is being tested for clinical use in allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of hematological malignancies. Additionally, the Company is developing its first product based on its platform, the ApoTainer selection kit that utilizes FasL-coated paramagnetic beads.

Webull offers kinds of Cellect Biotechnology Ltd - ADR stock information, including NASDAQ:APOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APOP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APOP stock methods without spending real money on the virtual paper trading platform.